Clinical Trials Browser

Phase EARLY_PHASE1 × Interventional × apatinib × Clear all

NCT04074564 2023-10-23

MASCT-I Combined With Apatinib and/or Camrelizumab in the Treatment of Bone and Soft Tissue Sarcoma

Phase EARLY_PHASE1 Unknown

Sarcoma